The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01133197|
Recruitment Status : Completed
First Posted : May 28, 2010
Last Update Posted : June 29, 2015
|Condition or disease|
This study is designed to define the impact of thumb arthritis on patient's general health. As a secondary objective, data will be analyzed to determine the effects of medical and musculoskeletal comorbidities on the rating of upper extremity function by the patient.
Potential Contribution: The data that we intend to gather could further our understanding of the overall health impact of thumb osteoarthritis and allow surgeons to more accurately interpret patient-rated measures of upper extremity function in the presence of comorbidities.
Osteoarthritis of the thumb carpometacarpal joint is one of the most common sites of arthritic degeneration in the hand. To date, no study has examined this conditions impact on overall health using a validated health measure (e.g. SF-36). Additionally, no study has examined the impact of medical and musculoskeletal comorbidities on patient-rated measures of upper extremity function in these patients.
|Study Type :||Observational|
|Actual Enrollment :||188 participants|
|Observational Model:||Case Control|
|Official Title:||The Impact of Thumb Carpometacarpal Osteoarthritis on General Health|
|Study Start Date :||July 2009|
|Actual Primary Completion Date :||June 2015|
|Actual Study Completion Date :||June 2015|
No hand arthritis
Patients with arthritis
- Hand Function [ Time Frame: Baseline ]Use of hand by Michigan Hand Questionnaire
- Overall Health [ Time Frame: Baseline ]SF-36
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01133197
|United States, Missouri|
|Barnes Jewish Hospital|
|St Louis, Missouri, United States, 63110|
|Principal Investigator:||Ryan P Calfee, MD||Washington University School of Medicine|